KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Unitedhealth (UNH) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Unitedhealth (UNH) over the last 17 years, with Q3 2025 value amounting to $686.0 million.

  • Unitedhealth's Tax Provisions fell 4941.0% to $686.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 2339.19%. This contributed to the annual value of $4.8 billion for FY2024, which is 1908.51% down from last year.
  • Per Unitedhealth's latest filing, its Tax Provisions stood at $686.0 million for Q3 2025, which was down 4941.0% from $510.0 million recorded in Q2 2025.
  • Unitedhealth's 5-year Tax Provisions high stood at $1.7 billion for Q3 2023, and its period low was $510.0 million during Q2 2025.
  • Moreover, its 5-year median value for Tax Provisions was $1.3 billion (2022), whereas its average is $1.3 billion.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 4221.98% in 2022, then plummeted by 5900.32% in 2025.
  • Unitedhealth's Tax Provisions (Quarter) stood at $919.0 million in 2021, then skyrocketed by 42.22% to $1.3 billion in 2022, then fell by 9.41% to $1.2 billion in 2023, then decreased by 14.95% to $1.0 billion in 2024, then tumbled by 31.88% to $686.0 million in 2025.
  • Its Tax Provisions was $686.0 million in Q3 2025, compared to $510.0 million in Q2 2025 and $1.6 billion in Q1 2025.